29. Myocarditis with Drs. JoAnn Lindenfeld, Javid Moslehi and Dr. Enrico Ammirati: Part 1
Cardiovascular experts, Drs. JoAnn Lindenfeld, Javid Moslehi and Richa Gupta from Vanderbilt University Medical Center and Dr. Enrico Ammirati from Milan, Italy join Amit and Dan for a two part discussion about all things to consider for myocarditis in general (part 1) and COVID-19 myocarditis and heart transplantation in the COVID-19 era (part 2). Flutter Moment/Song by Drs. Matt (Internal Medicine) and Beth Faiman (Oncology).\n\n\n\nOn the CardioNerds Myocarditis page you will find podcast episodes,\xa0infographic,\xa0youtube videos,\xa0references,\xa0tweetorials\xa0and\xa0guest experts & contributors,\xa0flutter stars\xa0and so much more.\n\n\n\nTake me to the Myocarditis Series Page\xa0Take me to the COVID-19 Series PageTake me to the Episode Topics Page\n\n\n\nInterview Questions\n\n\n\nWhat is myocarditis?How do we classify it?How do we diagnose myocarditis?Why don\u2019t we biopsy everyone?When do we think biopsy may change management?Do we\xa0really understand the mechanism of myocardial injury in what we call myocarditis?How do we figure mechanisms out and why is this important?\n\n\n\n\n\n\n\nGuests and Experts\n\n\n\nDr. JoAnn Lindenfeld, is a Professor of Medicine and the Director of Heart Failure and Heart Transplantation Section at Vanderbilt Heart and Vascular Institute.\xa0\xa0She is the past president of the Heart Failure Society of America and serves on editorial boards of numerous journals including JACC, JACC Heart Failure and JHLT.\xa0 She is also a member of the AHA/ACC/HFSA heart failure guideline writing committee and was previously chair of the HFSA practice guidelines for the 2006 and 2010 guidelines. In addition to this she\u2019s been an investigator in multiple large-scale clinical trials including the COAPT trial and has served on numerous steering committees, end point committees and data and safety monitoring committees. She is the author of a more than 300 original papers, reviews, and book chapters in the field of heart failure and heart transplantation.\n\n\n\nDr. Javid Moslehi\xa0is an associate professor of medicine at Vanderbilt University Medical Center where he is the director of the cardio-oncology program.\xa0 He is a clinical cardiologist and basic/translational biologist interested in cardiovascular complications associated with novel molecular targeted cancer therapies and the implications of these on our knowledge of basic cardiovascular biology. At Vanderbilt he runs an independent basic and translational research laboratory and program with a focus on signal transduction in the myocardium and vasculature as well as establishing pre-clinical models of cardiotoxicity involving novel targeted oncologic therapies.\n\n\n\nDr. Enrico Ammirati is an assistant professor of cardiology and advanced heart failure and transplant cardiologist in Milan, Italy at the Niguarda Hospital with a special research interest and expertise in acute myocarditis and acute heart failure.\xa0 He is a fellow of the European Society of Cardiology and has won numerous awards, he has also published incredibly important work on the distinction between fulminant and nonfulminant myocarditis and the prognostic implication of histologic subtypes.\xa0 His research interests also include the role of adaptive immunity in heart transplantation and atherosclerosis and he is the author of well over 100+ peer reviewed publications.\n\n\n\nJoAnn Lindenfeld, MDEnrico Ammirati, MDJavid Moslehi, MDMyocarditis Infographic